Oncology

Colorectal cancer (CRC) ranks as the third most common type of cancer in women. Patients aged 50 years and above constitute the highest percentage of patients diagnosed with the disease.

This article discusses how molecular pathology fits alongside traditional anatomical pathology, and the role of molecular MDTs in the management of patients with cancer.

EMJ conducted interviews in February 2022 with two key opinion leaders (KOL), Zachary Wilmer Reichenbach, who works in the Department of…

Clinical laboratories worldwide are implementing next-generation sequencing (NGS) to identify cancer genomic variants and ultimately…

This article reviews the impact of CINV, the emetogenic risk associated with different chemotherapy regimens in solid tumours and haematologic malignancies, and guideline-based recommendations for antiemetic prophylaxis according to emetogenic risk.

Over the last few years, advances in molecular biology and genome sequencing have made it possible to identify the genetic alterations that underlie different health conditions, and these advances are particularly important in the field of oncology. Thanks to these advanced techniques, there has been a change in the way a disease as complex and heterogeneous as breast cancer (BC) is understood.

Schwannomas are neurogenic, benign, slow growing tumours that originate in Schwann’s intersecting fascicles…

Around 15–20% of breast cancers are characterised by amplification or overexpression of human epidermal growth factor receptor 2 (HER2)…